This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Sep 30;351(14):1385-7.

doi: 10.1056/NEJMp048187.

Expecting the unexpected--drug safety, pharmacovigilance, and the prepared mind

Anne Trontell¹

Affiliations

PMID: 15459298
DOI: 10.1056/NEJMp048187

Comment

Expecting the unexpected--drug safety, pharmacovigilance, and the prepared mind

Anne Trontell. N Engl J Med. 2004.

. 2004 Sep 30;351(14):1385-7.

doi: 10.1056/NEJMp048187.

Author

Anne Trontell¹

Affiliation

¹ Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Md, USA.

PMID: 15459298
DOI: 10.1056/NEJMp048187

No abstract available

PubMed Disclaimer

Comment on

Pure red-cell aplasia and epoetin therapy.
Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N. Bennett CL, et al. N Engl J Med. 2004 Sep 30;351(14):1403-8. doi: 10.1056/NEJMoa040528. N Engl J Med. 2004. PMID: 15459301

Similar articles

Epoetin and pure red-cell aplasia.
Braun MM, Wise RP, Wood JJ. Braun MM, et al. N Engl J Med. 2005 Feb 3;352(5):511-2; author reply 511-2. doi: 10.1056/NEJM200502033520518. N Engl J Med. 2005. PMID: 15689594 No abstract available.
Pure red-cell aplasia and recombinant erythropoietin.
Gershon SK, Luksenburg H, Coté TR, Braun MM. Gershon SK, et al. N Engl J Med. 2002 May 16;346(20):1584-6; author reply 1584-6. doi: 10.1056/NEJM200205163462015. N Engl J Med. 2002. PMID: 12015400 No abstract available.
Eprex-associated pure red cell aplasia and leachates.
Schellekens H, Jiskoot W. Schellekens H, et al. Nat Biotechnol. 2006 Jun;24(6):613-4. doi: 10.1038/nbt0606-613. Nat Biotechnol. 2006. PMID: 16763579 No abstract available.
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Evens AM, Bennett CL, Luminari S. Evens AM, et al. Best Pract Res Clin Haematol. 2005;18(3):481-9. doi: 10.1016/j.beha.2005.01.017. Best Pract Res Clin Haematol. 2005. PMID: 15792923 Review.
[Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].
Grzegorzewska AE, Sucharzewska-Tomczak M. Grzegorzewska AE, et al. Pol Merkur Lekarski. 2004 Oct;17(100):407-9. Pol Merkur Lekarski. 2004. PMID: 15690716 Review. Polish.

See all similar articles

Cited by

Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work.
Bennett CL, Hoque S. Bennett CL, et al. Cancer Treat Res. 2022;184:129-140. doi: 10.1007/978-3-031-04402-1_9. Cancer Treat Res. 2022. PMID: 36449193
Data mining in the US using the Vaccine Adverse Event Reporting System.
Iskander J, Pool V, Zhou W, English-Bullard R; VAERS Team. Iskander J, et al. Drug Saf. 2006;29(5):375-84. doi: 10.2165/00002018-200629050-00002. Drug Saf. 2006. PMID: 16689554 Review.
Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.
Khan LM. Khan LM. Eur J Clin Pharmacol. 2013 Dec;69(12):1985-96. doi: 10.1007/s00228-013-1563-z. Epub 2013 Aug 17. Eur J Clin Pharmacol. 2013. PMID: 23955174
Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.
Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Golomb BA, et al. Drug Saf. 2007;30(8):669-75. doi: 10.2165/00002018-200730080-00003. Drug Saf. 2007. PMID: 17696579
Data mining in pharmacovigilance: the need for a balanced perspective.
Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Hauben M, et al. Drug Saf. 2005;28(10):835-42. doi: 10.2165/00002018-200528100-00001. Drug Saf. 2005. PMID: 16180934

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.